Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder

Major depressive disorder (MDD) is a serious mental disease with negative effects on both mental and physical health of the patient. Currently, antidepressants are among the major ways to ease or treat MDD. However, the existing antidepressants have limited efficacy in treating MDD, with a large fra...

Full description

Bibliographic Details
Main Authors: Juncai Xin, Meng Yuan, Yonglin Peng, Ju Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00151/full
_version_ 1811295014754451456
author Juncai Xin
Meng Yuan
Yonglin Peng
Ju Wang
author_facet Juncai Xin
Meng Yuan
Yonglin Peng
Ju Wang
author_sort Juncai Xin
collection DOAJ
description Major depressive disorder (MDD) is a serious mental disease with negative effects on both mental and physical health of the patient. Currently, antidepressants are among the major ways to ease or treat MDD. However, the existing antidepressants have limited efficacy in treating MDD, with a large fraction of patients either responding inadequately or differently to antidepressants during the treatment. Pharmacogenetics studies have found that the genetic features of some genes are associated with the antidepressant efficacy. In order to obtain a better understanding on the relationship between the genetic factors and antidepressant treatment response, we compiled a list of 233 single-nucleotide polymorphisms (SNPs) significantly associated with the antidepressant efficacy in treating MDD. Of the 13 non-synonymous SNPs in the list, three (rs1065852, rs3810651, and rs117986340) may influence the structures and function of the corresponding proteins. Besides, the influence of rs1065852 on the structure of CYP2D6 was further investigated via molecular dynamics simulations. Our results showed that compared to the native CYP2D6 the flexibility of the F-G loop was reduced in the mutant. As a portion of the substrate access channel, the lower flexibility of F-G loop may reduce the ability of the substrates to enter the channel, which may be the reason for the lower enzyme activity of mutant. This study may help us to understand the impact of genetic variation on antidepressant efficacy and provide clues for developing new antidepressants.
first_indexed 2024-04-13T05:27:03Z
format Article
id doaj.art-e029444748c6468c95000ecb4247f33d
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-04-13T05:27:03Z
publishDate 2020-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-e029444748c6468c95000ecb4247f33d2022-12-22T03:00:34ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402020-03-011110.3389/fpsyt.2020.00151513924Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive DisorderJuncai XinMeng YuanYonglin PengJu WangMajor depressive disorder (MDD) is a serious mental disease with negative effects on both mental and physical health of the patient. Currently, antidepressants are among the major ways to ease or treat MDD. However, the existing antidepressants have limited efficacy in treating MDD, with a large fraction of patients either responding inadequately or differently to antidepressants during the treatment. Pharmacogenetics studies have found that the genetic features of some genes are associated with the antidepressant efficacy. In order to obtain a better understanding on the relationship between the genetic factors and antidepressant treatment response, we compiled a list of 233 single-nucleotide polymorphisms (SNPs) significantly associated with the antidepressant efficacy in treating MDD. Of the 13 non-synonymous SNPs in the list, three (rs1065852, rs3810651, and rs117986340) may influence the structures and function of the corresponding proteins. Besides, the influence of rs1065852 on the structure of CYP2D6 was further investigated via molecular dynamics simulations. Our results showed that compared to the native CYP2D6 the flexibility of the F-G loop was reduced in the mutant. As a portion of the substrate access channel, the lower flexibility of F-G loop may reduce the ability of the substrates to enter the channel, which may be the reason for the lower enzyme activity of mutant. This study may help us to understand the impact of genetic variation on antidepressant efficacy and provide clues for developing new antidepressants.https://www.frontiersin.org/article/10.3389/fpsyt.2020.00151/fullmajor depressive disorderantidepressantsnon-synonymous SNPsprotein structuremolecular dynamics simulations
spellingShingle Juncai Xin
Meng Yuan
Yonglin Peng
Ju Wang
Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
Frontiers in Psychiatry
major depressive disorder
antidepressants
non-synonymous SNPs
protein structure
molecular dynamics simulations
title Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
title_full Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
title_fullStr Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
title_full_unstemmed Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
title_short Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
title_sort analysis of the deleterious single nucleotide polymorphisms associated with antidepressant efficacy in major depressive disorder
topic major depressive disorder
antidepressants
non-synonymous SNPs
protein structure
molecular dynamics simulations
url https://www.frontiersin.org/article/10.3389/fpsyt.2020.00151/full
work_keys_str_mv AT juncaixin analysisofthedeleterioussinglenucleotidepolymorphismsassociatedwithantidepressantefficacyinmajordepressivedisorder
AT mengyuan analysisofthedeleterioussinglenucleotidepolymorphismsassociatedwithantidepressantefficacyinmajordepressivedisorder
AT yonglinpeng analysisofthedeleterioussinglenucleotidepolymorphismsassociatedwithantidepressantefficacyinmajordepressivedisorder
AT juwang analysisofthedeleterioussinglenucleotidepolymorphismsassociatedwithantidepressantefficacyinmajordepressivedisorder